AWARENESS OF KOREAN DENTISTS ON BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAWS : PRELIMINARY REPORT |
Park, Yong-Duck
(Department of Preventive and Public Health Dentistry, School of Medicine, Kyung Hee University)
Kim, Young-Ran (Department of Oral & Maxillofacial Surgery, School of Dentistry, School of Medicine, Kyung Hee University) Kim, Deog-Yoon (Department of Nuclear Medicine, School of Medicine, Kyung Hee University) Chung, Yoon-Sok (Department of Endocrinology, Ajuo University School of Medicine) Lee, Jeung-Keun (Department of Dentistry, Ajuo University School of Medicine) Kim, Yeo-Gab (Department of Oral & Maxillofacial Surgery, School of Dentistry, School of Medicine, Kyung Hee University) Kwon, Yong-Dae (Department of Oral & Maxillofacial Surgery, School of Dentistry, School of Medicine, Kyung Hee University) |
1 | 국민건강보험공단 2007통계연보, 대한민국, 2008 |
2 | Bize R, Lamy O, Peytremann-Bridevaux I. Osteoporotic fracture in menopausal women: alendronate reduces the risk. Rev MedSuisse. 2008 Dec 10;4:2703 |
3 | American Association of Oral & Maxillofacial Surgeons. 2006 position paper on Bisphosphonate-related osteonecrosis of the jaw. Available at http://www.aamos.org/2006 |
4 | Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JAet al. Once-yearly zoledronic acid for treatment of postmenopausalosteoporosis. N Eng1 J Med 2007;356:1809-22 DOI ScienceOn |
5 | Altundag K, Bulut N, Tezcan E, Ozen M, Purnak T. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates? J OralMaxillofac Surg 2007;65:154 DOI ScienceOn |
6 | Bagan JV, Murillo J, Jimenez Y. Avascular jaw osteonecrosis inassociation with cancer chemotherapy : series of 10 cases. J OralPathol Med 2005;34:120-3 DOI ScienceOn |
7 | Groetz KA, Al-Nawas B. Persisting alveolar sockets-a radiologic symptom of BP-ONJ. J Oral Maxillofac Surg 2006;64:1571-2 DOI ScienceOn |
8 | http://www.nso.go.kr/ |
9 | Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) inducedavascular necrosis of the jaw : a growing epidemic. J OralMaxillofac Surg 2003;61:1115-7 DOI ScienceOn |
10 | Haderslev KV, Tjellesen L, Sorensen HA et al. Alendronate increaseslumbar spine bone mineral density in patients withCrohn's disease. Gastroenterology 2000;119:639-46 DOI ScienceOn |
11 | Grotz KA. Zahnarztliche Betreuung von Patienten mit tumortherapeutischerKopf-Hals-Bestrahlung (Stellungnahme der DGZMKund DEGRO). Dtsch Zahnrztl Z. 2002;57:509 |
12 | Hansen T, Kunkel M, Weber A, James Kirkpatrick C.Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis.J Oral Pathol Med 2006;35:155-60 DOI ScienceOn |
13 | National Osteoporosis Foundation. American's Bone Health. Available at http://nof.org/advocacy/prevalence/index.htm |
14 | Schilling J. Management of bisphosphonate-induced osteonecrosis of the jaw. Northwest Dent. 2008;87:34-5,37-8, 40 PUBMED ScienceOn |
15 | Walter C, Grotz KA, Kunkel M, Al-Nawas B. Prevalence of bisphosphonateassociated osteonecrosis of the jaw within the fieldof osteonecrosis. Support Care Cancer 2007;15:197-202 DOI ScienceOn |
16 | Dimitrakopoulos I. Magopoulos C, Karakasis D. Bisphos-phonateinducedavascular osteonecrosis of the jaws: a clinical report of 11cases. Int J Oral Maxillofac Surg 2006;35:588-93 DOI ScienceOn |
17 | Ruggiero SL. Mehrotra B. Rosenberg TJ. Osteonecrosis of thejaws associated with the use of bisphosphonates : a review of 63cases. J Oral Maxillofac Surg 2004;62:527-34 DOI ScienceOn |
18 | Kwon YD, Yoon BW, Walter C. Bisphosphonate, is it an emergingrisk factor in oral surgery? J Korean Assoc Maxillofac PlastReconstr Surg 2007;29:456-62 |